Please login to the form below

Not currently logged in
Email:
Password:

pain management

This page shows the latest pain management news and features for those working in and with pharma, biotech and healthcare.

Big Pharma, Little Pharma

Big Pharma, Little Pharma

to dominate a particular ecological niche. Think penguins or wildebeest. We see other firms attempting similar evolution, such as Grunenthal with pain management and Ferring with women’s health.

Latest news

  • AcelRX’s potent opioid tablets set to win FDA backing for pain relief AcelRX’s potent opioid tablets set to win FDA backing for pain relief

    We look forward to continued collaboration with the FDA on the application as we believe Dsuvia represents an important non-invasive acute pain management option with potential to significantly improve the ... BMIs. Meanwhile, Trevena’s intravenous

  • FDA awards another non-opioid pain drug breakthrough status FDA awards another non-opioid pain drug breakthrough status

    FDA awards another non-opioid pain drug breakthrough status. Second drug fast-tracked amid addiction epidemic. ... The announcement follows a BTD in June for Heron Therapeutics and its HTX-011, also for post-operative pain management.

  • Heron boosted by new data for ‘breakthrough’ pain drug Heron boosted by new data for ‘breakthrough’ pain drug

    Heron boosted by new data for ‘ breakthrough’ pain drug. Shares jumped by a third after trial announcement. ... for postoperative pain management, in phase III studies, ”said Barry Quart, Heron’s chief executive.

  • The year of the blockbuster The year of the blockbuster

    Elagolix was filed for approval in the US in September 2017 for the management of endometriosis with associated pain. ... Endometriosis has no cure and requires symptomatic treatment. and a life-long management plan.

  • Europe's public-private alliance targets pain management Europe's public-private alliance targets pain management

    Europe's public-private alliance targets pain management. Innovative Medicines Initiative (IMI) brings pharma together with academia and patient groups in underserved area. ... Acute and persistent pain of different origins represent a common medical,

More from news
Approximately 2 fully matching, plus 73 partially matching documents found.

Latest Intelligence

  • Stepping out Stepping out

    For example, a recent study of pain management in Europe showed that some patients weren’t taking their medicines appropriately because they had concerns about becoming addicted.

  • How digital content helps HCPs curb opioid abuse through better prescribing decisions How digital content helps HCPs curb opioid abuse through better prescribing decisions

    On the other hand are the prescribers who are driven to help their patients but who are finding that their pain management protocols are now complicated by the treatment of an ... The pain management topic found under most specialties at Univadis

  • Deal Watch March 2016 Deal Watch March 2016

    Both companies have dermatology portfolios and with the acquisition of Putney, Dechra has also added anti-infective and pain management products to its own portfolio of endocrinology and ophthalmology products.

  • Pharma deals in June 2015 Pharma deals in June 2015

    Licence, collaboration. 364. Spinifex Pharmaceuticals/ Novartis. Lead candidate EMA401 - oral treatment for chronic pain, particularly neuropathic pain (p2). ... Neosaxitoxin, novel anaesthetic for local anaesthesia and post-op pain management.

  • Pharma deals during August 2014 Pharma deals during August 2014

    CL-108 has recently successfully completed a phase 3 study in the treatment of moderate to severe acute pain and the reduction of OINV. ... This acquisition will compliment and strengthen Medtronic's neuromodulation leadership position in the areas of

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics